RT Journal Article
SR Electronic
T1 Machine learning dimensionality reduction for heart rate n-variability (HRnV) based risk stratification of chest pain patients in the emergency department
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.05.20146571
DO 10.1101/2020.07.05.20146571
A1 Liu, Nan
A1 Chee, Marcel Lucas
A1 Koh, Zhi Xiong
A1 Leow, Su Li
A1 Wah Ho, Andrew Fu
A1 Guo, Dagang
A1 Hock Ong, Marcus Eng
YR 2020
UL http://medrxiv.org/content/early/2020/07/06/2020.07.05.20146571.abstract
AB Background Chest pain is among the most common presenting complaints in the emergency department (ED). Swift and accurate risk stratification of chest pain patients in the ED may improve patient outcomes and reduce unnecessary costs. Traditional logistic regression with stepwise variable selection has been used to build risk prediction models for ED chest pain patients. In this study, we aimed to investigate if machine learning dimensionality reduction methods can achieve superior performance than the stepwise approach in deriving risk stratification models.Methods A retrospective analysis was conducted on the data of patients >20 years old who presented to the ED of Singapore General Hospital with chest pain between September 2010 and July 2015. Variables used included demographics, medical history, laboratory findings, heart rate variability (HRV), and HRnV parameters calculated from five to six-minute electrocardiograms (ECGs). The primary outcome was 30-day major adverse cardiac events (MACE), which included death, acute myocardial infarction, and revascularization. Candidate variables identified using univariable analysis were then used to generate the stepwise logistic regression model and eight machine learning dimensionality reduction prediction models. A separate set of models was derived by excluding troponin. Receiver operating characteristic (ROC) and calibration analysis was used to compare model performance.Results 795 patients were included in the analysis, of which 247 (31%) met the primary outcome of 30-day MACE. Patients with MACE were older and more likely to be male. All eight dimensionality reduction methods marginally but non-significantly outperformed stepwise variable selection; The multidimensional scaling algorithm performed the best with an area under the curve (AUC) of 0.901. All HRnV-based models generated in this study outperformed several existing clinical scores in ROC analysis.Conclusions HRnV-based models using stepwise logistic regression performed better than existing chest pain scores for predicting MACE, with only marginal improvements using machine learning dimensionality reduction. Moreover, traditional stepwise approach benefits from model transparency and interpretability; in comparison, machine learning dimensionality reduction models are black boxes, making them difficult to explain in clinical practice.Competing Interest StatementNL and MEHO hold patents related to using heart rate variability and artificial intelligence for medical monitoring. NL, ZXK, DG, and MEHO are currently advisers to TIIM SG. The other authors report no conflicts.Funding StatementThis work was supported by the Duke-NUS Signature Research Programme funded by the Ministry of Health, Singapore. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethical approval was obtained from the Centralized Institutional Review Board (CIRB, Ref: 2014/584/C) of SingHealth, in which patient consent was waived.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.ACSacute coronary syndromeAMIacute myocardial infarctionAUCarea under the curveApEnapproximate entropyCIconfidence intervalsCABGcoronary artery bypass graftCOVID-19coronavirus disease 2019DFAdetrended fluctuation analysisECGelectrocardiogramEHRelectronic health recordsEDemergency departmentGRPGaussian random projectionGRACEglobal registry of acute coronary eventsHRnVheart rate n-variabilityHRVheart rate variabilityHFhigh frequencyHEARTHistory, ECG, Age, Risk factors, and initial TroponinIQRinterquartile rangeKPCAkernel principal component analysisLSAlatent semantic analysisLLElocally linear embeddingLFlow frequencyMACEmajor adverse cardiac eventsMean NNaverage of R-R intervalsMDSmultidimensional scalingNPVnegative predictive valueNN50the number of times that the absolute difference between 2 successive R-R intervals exceeds 50 msNN50nthe number of times that the absolute difference between 2 successive RRnI/RRnIm sequences exceeds 50×n msPACSpatient acuity category scale PCI, percutaneous coronary interventionpNN50NN50 divided by the total number of R-R intervalspNN50nNN50n divided by the total number of RRnI/RRnIm sequences PPV, positive predictive valuePCAprincipal component analysisROCreceiver operating characteristicRMSSDsquare root of the mean squared differences between R-R intervalsRRIR-R intervalSampEnsample entropySDstandard deviationSDNNstandard deviation of R-R intervalsSRPsparse random projectionSTEMIST-elevation myocardial infarctionTIMIthrombolysis in myocardial infarctionVLFvery low frequency